This trial looks at giving capecitabine & temozolomide after surgery to patients with a certain kind of pancreatic tumor. These drugs work in different ways to stop the growth of tumor cells. This could prevent or delay the return of cancer in these patients.
- Stage II Pancreatic Neuroendocrine Tumor
- Liver Cancer
- Stage III Pancreatic Neuroendocrine Tumor
- Stage I Pancreatic Neuroendocrine Tumor
- Pancreatic Neuroendocrine Tumors
1 Primary · 2 Secondary · Reporting Duration: From date of registration to date of death due to any cause, assessed up to 5 years
Side Effects for
Awards & Highlights
2 Treatment Groups
Arm II (surveillance)
1 of 2
Arm I (capecitabine, temozolomide)
1 of 2
141 Total Participants · 2 Treatment Groups
Primary Treatment: Capecitabine · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any available slots for new patients in this research project?
"This study is currently recruiting participants, as indicated on clinicaltrials.gov. The trial was originally posted on October 14th, 2021 and was last updated on December 3rd, 2021." - Anonymous Online Contributor
Are there potentially fatal side effects to taking Capecitabine?
"While there is some data suggesting capecitabine is safe, as this is only a Phase 2 trial, there is no clinical evidence yet to support its efficacy. Consequently, it received a score of 2." - Anonymous Online Contributor
What are some other research projects that have used Capecitabine?
"As of now, there are 561 total trials regarding Capecitabine with 153 being in the third stage. Although many studies for this treatment are based in Woolloongabba, Queensland, there are a whopping 16764 locations running clinical trials for it." - Anonymous Online Contributor
How many people can join this research project?
"That is correct. The clinical trial, which began recruitment on October 14th 2021, is still looking for patients. There have been no changes to the 6 participating sites or the 141 patient goal since December 3rd 2021." - Anonymous Online Contributor
For what purpose is Capecitabine most often prescribed?
"Capecitabine is a medication that can be used to manage progression, disease. It has also been shown to help patients with nitrosourea treatment, advance directives, and refractory, advanced mycosis fungoides." - Anonymous Online Contributor
Is this an innovative clinical trial?
"There are 561 ongoing studies for the medication Capecitabine in 70 different countries. The first study was held 18 years ago and involved 60 patients. It completed Phase 2 of testing in 2002 and was sponsored by Schering-Plough. Since that time, 843 total studies have been completed." - Anonymous Online Contributor
At how many hospitals is this research being conducted?
"There are six medical centers participating in this study, located in Ames, Fort Dodge, Boone, and other cities." - Anonymous Online Contributor